search
Back to results

Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases (METALAP)

Primary Purpose

Liver Metastasis Colon Cancer, Postoperative Complications

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
hepatectomy
Sponsored by
Institut Mutualiste Montsouris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Liver Metastasis Colon Cancer focused on measuring Liver resection, Laparoscopy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Presenting with colorectal liver metastases requiring liver resection ± concomitant radiofrequency ablation.
  • Qualifying for both a laparoscopic approach and an open approach.
  • Informed written consent.
  • Affiliated to health insurance regimen.

Exclusion Criteria:

  • Hybrid liver resection (including both laparoscopic and open resection).
  • Liver resection requiring an associated vascular or biliary reconstruction.
  • Contraindication to surgery.
  • Contraindication to laparoscopy (pneumoperitoneum).
  • ASA (American Society of Anesthesiologists) score IV or V or life expectancy < 3 months.
  • Poor comprehension of French language or cognitive impairment
  • Pregnancy or breastfeeding.
  • Patient under guardianship or unable to give consent
  • People particularly protected by French law.

Sites / Locations

  • CHU Amiens Picardie
  • Hôpital Côte de Nacre - Chu Caen
  • CHU Estaing
  • Hôpital BeaujonRecruiting
  • CHU Henri MondorRecruiting
  • CHU de Grenoble
  • Hôpital Claude Huriez
  • HCL - Hôpital Croix Rousse
  • CHU de Marseille Hôpital de Timone
  • l'Institut Paoli Calmettes
  • CHU de Montpellier
  • CHU de Nancy - Hôpitaux Brabois
  • Institut Mutualiste MontsourisRecruiting
  • Hôpital CochinRecruiting
  • Hôpital La pitié SalpêtrièreRecruiting
  • CHU de Reims
  • Hôpital Charles Nicolle
  • CHU de Strasbourg - Nouvel Hôpital Civil
  • CHU Rangueil
  • Hôpital Trousseau
  • Hôpital Paul BrousseRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

laparoscopic liver resection

open liver resection

Arm Description

Laparoscopy allows some surgical procedures to be performed through small incisions that enable the operator to access the abdominal cavity, often at the pubic area, and surgical instruments are introduced through these small incisions. This technique avoids large abdominal incisions and significantly reduces the duration of hospitalization.

standard of care

Outcomes

Primary Outcome Measures

Rate of overall complications using the comprehensive complication Index (CCI)
CCI is calculated using the burden of postoperative complications weighted with a measure of the severity according to the widely accepted Dindo-Clavien classification of postoperative complications and a dedicated CCI calculator.

Secondary Outcome Measures

Proportion of patients presenting severe postoperative complications
Proportion of patients presenting severe postoperative complications rate as defined by the Clavien-Dindo classification ≥ grade 3 (including mortality) between patients treated with laparoscopic liver resection and those treated with open liver surgery
Rate of conversion from laparoscopy liver resection to open liver surgery
Conversion is defined as the requirement for laparotomy at any time of the procedure with the exception of the extraction of the resected specimen. Specific data regarding conversion will be noticed from the operative reports. These included the reasons for conversion, the timing of conversion and the type of conversion.
Length of hospital stay
Length of hospital stay and occurrence of unplanned readmission after discharge,assessed by hospitalization reports
Delay of recovery before resuming professional activities.
Delay of recovery before resuming professional activities assessed by PQRS (Postoperative Quality Recovery Scale) including nociceptive domain, emotional domain, cognition domain and day-to-day activities at D-1, D1, D7, D30 and D90.
Postoperative quality of life using quality of life questionnaries.
Patient-reported outcome measures were assessed with the validated European Organisation for Research and Treatment of Cancer (EORTC) score questionnaire, EORTC Quality of Life Questionnaire (QLQ) -C30 (version 3.0), and the module dedicated to colorectal liver metastases (EORTC QLQ-LMC21). EQ5D-5L is a standardised measure of health status that provides a simple descriptive profile and a single index value suitable for the economic evaluation of health. It will be used to calculate the QALYs of each enrolled patient, by valuing health.
Health economics analysis
A cost-effectiveness study will be performed and completed by a cost-utility analysis to identify the efficient therapeutic strategy (laparoscopic approach) ompared to the reference (open surgery). Only direct costs will be considered for treatments, management of side effects, medical transports, rehabilitation procedures and medical consultations. Out of hospital resources are valued from the Social Health Insurance (SHI) tariffs and hospital stays the Diagnosis-Related group (DRG) tariff taking into account additional daily fixed prices for ICU stay, if any.
Oncologic quality of the resection using the pathological report.
Mean surgical margin widths (in millimeters). Percentages of microscopically complete (R0), microscopically incomplete (R1) and macroscopically incomplete (R2) resections as stated in the pathological report.
Disease-free and overall survival at 3 years.
Percentage of patients with intrahepatic or extrahepatic recurrence three years after the operation. Median disease-free survival time (in months). Percentage of patients who died at 1, 2 and 3 years after the procedure. Median overall survival time (in months).

Full Information

First Posted
October 21, 2019
Last Updated
February 21, 2022
Sponsor
Institut Mutualiste Montsouris
Collaborators
Ministry of Health, France, National Cancer Institute, France
search

1. Study Identification

Unique Protocol Identification Number
NCT04163887
Brief Title
Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases
Acronym
METALAP
Official Title
Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases: Prospective, Randomized, Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 27, 2021 (Actual)
Primary Completion Date
April 27, 2023 (Anticipated)
Study Completion Date
January 27, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut Mutualiste Montsouris
Collaborators
Ministry of Health, France, National Cancer Institute, France

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The objective of this study is to demonstrate the superiority of the laparoscopic approach over the open approach in the resection of colorectal liver metastases, by examining the reduction of postoperative complications (including mortality), measured using the Comprehensive Complication Index (CCI) within 90 days of the procedure or regardless of the date during the hospital stay.
Detailed Description
While laparotomy is still the standard approach of resectable colorectal liver mestastases, its associated morbidity remains non-negligible with reported mortality and complications rates ranging from 2 to 8% and 30 to 70%, respectively (1). Besides the underlying liver disease together with the comorbidities of the patients, this high morbidity is also related to the type of surgical approach. Since less than 15% of liver resections are currently performed using the laparoscopic approach in France, a trial showing the superiority of the laparoscopic approach in comparison to the open approach for patients with colorectal liver metastases qualifying for both approaches would allow improving management of patients, reducing the length of stay, maybe decreasing the global cost and changing current practices on a national scale. In order to demonstrate the superiority of the laparoscopic approach over the laparotomy approach, patients with colorectal hepatic metastasis will be randomly assigned to either the laparoscopy or laparotomy groups. Post-operative complications (including mortality) will be measured using the Comprehensive Complication Index (CCI) within 90 days postoperatively or at any time during hospitalization. The participation time for each patient in the study is 3 years, the patient will be followed at 1, 3, 6, 9, 9, 12, 15, 18, 21, 24, 30 and 36 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Metastasis Colon Cancer, Postoperative Complications
Keywords
Liver resection, Laparoscopy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective multicenter, open-label and pragmatic, controlled randomized (minimization procedure) superiority trial in 2 parallel groups comparing the rates of 90 days postoperative complications between patients undergoing laparoscopic and open liver resection for colorectal liver metastases.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
340 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
laparoscopic liver resection
Arm Type
Other
Arm Description
Laparoscopy allows some surgical procedures to be performed through small incisions that enable the operator to access the abdominal cavity, often at the pubic area, and surgical instruments are introduced through these small incisions. This technique avoids large abdominal incisions and significantly reduces the duration of hospitalization.
Arm Title
open liver resection
Arm Type
Other
Arm Description
standard of care
Intervention Type
Procedure
Intervention Name(s)
hepatectomy
Intervention Description
Resection colorectal liver metastases using a laparoscopic approach or an open approach.
Primary Outcome Measure Information:
Title
Rate of overall complications using the comprehensive complication Index (CCI)
Description
CCI is calculated using the burden of postoperative complications weighted with a measure of the severity according to the widely accepted Dindo-Clavien classification of postoperative complications and a dedicated CCI calculator.
Time Frame
Within 90 days postoperatively or at any time during hospitalization.
Secondary Outcome Measure Information:
Title
Proportion of patients presenting severe postoperative complications
Description
Proportion of patients presenting severe postoperative complications rate as defined by the Clavien-Dindo classification ≥ grade 3 (including mortality) between patients treated with laparoscopic liver resection and those treated with open liver surgery
Time Frame
Within 90 days postoperatively or at any time during hospitalization.
Title
Rate of conversion from laparoscopy liver resection to open liver surgery
Description
Conversion is defined as the requirement for laparotomy at any time of the procedure with the exception of the extraction of the resected specimen. Specific data regarding conversion will be noticed from the operative reports. These included the reasons for conversion, the timing of conversion and the type of conversion.
Time Frame
during surgery.
Title
Length of hospital stay
Description
Length of hospital stay and occurrence of unplanned readmission after discharge,assessed by hospitalization reports
Time Frame
Within 90 days postoperatively or at any time during hospitalization.
Title
Delay of recovery before resuming professional activities.
Description
Delay of recovery before resuming professional activities assessed by PQRS (Postoperative Quality Recovery Scale) including nociceptive domain, emotional domain, cognition domain and day-to-day activities at D-1, D1, D7, D30 and D90.
Time Frame
Within 90 days postoperatively
Title
Postoperative quality of life using quality of life questionnaries.
Description
Patient-reported outcome measures were assessed with the validated European Organisation for Research and Treatment of Cancer (EORTC) score questionnaire, EORTC Quality of Life Questionnaire (QLQ) -C30 (version 3.0), and the module dedicated to colorectal liver metastases (EORTC QLQ-LMC21). EQ5D-5L is a standardised measure of health status that provides a simple descriptive profile and a single index value suitable for the economic evaluation of health. It will be used to calculate the QALYs of each enrolled patient, by valuing health.
Time Frame
At the inclusion (before surgery), at 1 month postintervention, 3 months, 6 months and then every 6 months during 3 years.
Title
Health economics analysis
Description
A cost-effectiveness study will be performed and completed by a cost-utility analysis to identify the efficient therapeutic strategy (laparoscopic approach) ompared to the reference (open surgery). Only direct costs will be considered for treatments, management of side effects, medical transports, rehabilitation procedures and medical consultations. Out of hospital resources are valued from the Social Health Insurance (SHI) tariffs and hospital stays the Diagnosis-Related group (DRG) tariff taking into account additional daily fixed prices for ICU stay, if any.
Time Frame
During the full participation period (3 years).
Title
Oncologic quality of the resection using the pathological report.
Description
Mean surgical margin widths (in millimeters). Percentages of microscopically complete (R0), microscopically incomplete (R1) and macroscopically incomplete (R2) resections as stated in the pathological report.
Time Frame
During surgery
Title
Disease-free and overall survival at 3 years.
Description
Percentage of patients with intrahepatic or extrahepatic recurrence three years after the operation. Median disease-free survival time (in months). Percentage of patients who died at 1, 2 and 3 years after the procedure. Median overall survival time (in months).
Time Frame
During the full participation period (3 years).

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Presenting with colorectal liver metastases requiring liver resection ± concomitant radiofrequency ablation. Qualifying for both a laparoscopic approach and an open approach. Informed written consent. Affiliated to health insurance regimen. Exclusion Criteria: Hybrid liver resection (including both laparoscopic and open resection). Liver resection requiring an associated vascular or biliary reconstruction. Contraindication to surgery. Contraindication to laparoscopy (pneumoperitoneum). ASA (American Society of Anesthesiologists) score IV or V or life expectancy < 3 months. Poor comprehension of French language or cognitive impairment Pregnancy or breastfeeding. Patient under guardianship or unable to give consent People particularly protected by French law.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Caroline RIX
Phone
+33 156616371
Email
caroline.rix@imm.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Nassima OUDAFAL
Phone
+33 156616675
Email
nassima.oudafal@imm.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David FUKS, PR
Organizational Affiliation
Institut Mutualiste Montsouris
Official's Role
Study Chair
Facility Information:
Facility Name
CHU Amiens Picardie
City
Amiens
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Marc Regimbeau
Email
Regimbeau.Jean-Marc@chu-amiens.fr
Facility Name
Hôpital Côte de Nacre - Chu Caen
City
Caen
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
jean Lubrano
Email
lubrano-j@chu-caen.fr
Facility Name
CHU Estaing
City
Clermont-Ferrand
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emmanuel Buc
Email
ebuc@chu-clermontferrand.fr
Facility Name
Hôpital Beaujon
City
Clichy
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
François CAUCHY
Email
francois.cauchy@aphp.fr
Facility Name
CHU Henri Mondor
City
Créteil
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexis Laurent
Email
alexis.laurent@aphp.fr
Facility Name
CHU de Grenoble
City
Grenoble
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mircea Chirica
Email
mircea.chirica@chu-grenoble.fr
Facility Name
Hôpital Claude Huriez
City
Lille
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
François-René Pruvot
Email
francois-rene.pruvot@chru-lille.fr
Facility Name
HCL - Hôpital Croix Rousse
City
Lyon
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Yves Mabrut
Email
mabrut.jean-yves@chu-lyon.fr
Facility Name
CHU de Marseille Hôpital de Timone
City
Marseille
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean Hardwigsen
Email
Jean.HARDWIGSEN@ap-hm.fr
Facility Name
l'Institut Paoli Calmettes
City
Marseille
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivier Turrini
Email
turrinio@ipc.unicancer.fr
Facility Name
CHU de Montpellier
City
Montpellier
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Michel Fabre
Email
jean-michel.fabre@chu-montpellier.fr
Facility Name
CHU de Nancy - Hôpitaux Brabois
City
Nancy
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ahmet Ayav
Email
a.ayav@chu-nancy.fr
Facility Name
Institut Mutualiste Montsouris
City
Paris
ZIP/Postal Code
75014
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ecoline TRIBILLON, Dr
Email
ecoline.tribillon@imm.fr
Facility Name
Hôpital Cochin
City
Paris
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David FUKS
Email
david.fuks@aphp.fr
Facility Name
Hôpital La pitié Salpêtrière
City
Paris
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivier Scatton
Email
olivier.scatton@aphp.fr
Facility Name
CHU de Reims
City
Reims
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Reza Kianmanesh
Email
rkianmanesh@chu-reims.fr
Facility Name
Hôpital Charles Nicolle
City
Rouen
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lilian Schwarz
Email
lilian.schwarz@chu-rouen.fr
Facility Name
CHU de Strasbourg - Nouvel Hôpital Civil
City
Strasbourg
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrick Pessaux
Email
patrick.pessaux@chru-strasbourg.fr
Facility Name
CHU Rangueil
City
Toulouse
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fabrice Muscari
Email
muscari.f@chu-toulouse.fr
Facility Name
Hôpital Trousseau
City
Tours
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ephrem Salamé
Email
e.salame@chu-tours.fr
Facility Name
Hôpital Paul Brousse
City
Villejuif
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daniel Cherqui
Email
daniel.cherqui@aphp.fr

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25559415
Citation
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
Results Reference
background
PubMed Identifier
16858188
Citation
Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006 Aug;244(2):254-9. doi: 10.1097/01.sla.0000217629.94941.cf.
Results Reference
background
PubMed Identifier
20368552
Citation
Power DG, Kemeny NE. Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol. 2010 May 1;28(13):2300-9. doi: 10.1200/JCO.2009.26.9340. Epub 2010 Apr 5.
Results Reference
background
PubMed Identifier
28111192
Citation
Komatsu S, Scatton O, Goumard C, Sepulveda A, Brustia R, Perdigao F, Soubrane O. Development Process and Technical Aspects of Laparoscopic Hepatectomy: Learning Curve Based on 15 Years of Experience. J Am Coll Surg. 2017 May;224(5):841-850. doi: 10.1016/j.jamcollsurg.2016.12.037. Epub 2017 Jan 20.
Results Reference
background
PubMed Identifier
25607769
Citation
Fuks D, Cauchy F, Fteriche S, Nomi T, Schwarz L, Dokmak S, Scatton O, Fusco G, Belghiti J, Gayet B, Soubrane O. Laparoscopy Decreases Pulmonary Complications in Patients Undergoing Major Liver Resection: A Propensity Score Analysis. Ann Surg. 2016 Feb;263(2):353-61. doi: 10.1097/SLA.0000000000001140.
Results Reference
background
PubMed Identifier
26641255
Citation
Nomi T, Fuks D, Ogiso S, Nakajima Y, Louvet C, Gayet B. Second and Third Laparoscopic Liver Resection for Patients With Recurrent Colorectal Liver Metastases. Ann Surg. 2016 May;263(5):e68-72. doi: 10.1097/SLA.0000000000001528. No abstract available.
Results Reference
background
PubMed Identifier
26700223
Citation
Ciria R, Cherqui D, Geller DA, Briceno J, Wakabayashi G. Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing. Ann Surg. 2016 Apr;263(4):761-77. doi: 10.1097/SLA.0000000000001413.
Results Reference
background
PubMed Identifier
28717911
Citation
Hallet J, Sa Cunha A, Cherqui D, Gayet B, Goere D, Bachellier P, Laurent A, Fuks D, Navarro F, Pessaux P; French Colorectal Liver Metastases Working Group, Association Francaise de Chirurgie. Laparoscopic Compared to Open Repeat Hepatectomy for Colorectal Liver Metastases: a Multi-institutional Propensity-Matched Analysis of Short- and Long-Term Outcomes. World J Surg. 2017 Dec;41(12):3189-3198. doi: 10.1007/s00268-017-4119-z.
Results Reference
background
PubMed Identifier
28657937
Citation
Fretland AA, Dagenborg VJ, Bjornelv GMW, Kazaryan AM, Kristiansen R, Fagerland MW, Hausken J, Tonnessen TI, Abildgaard A, Barkhatov L, Yaqub S, Rosok BI, Bjornbeth BA, Andersen MH, Flatmark K, Aas E, Edwin B. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg. 2018 Feb;267(2):199-207. doi: 10.1097/SLA.0000000000002353.
Results Reference
background
PubMed Identifier
27695941
Citation
Gilg S, Sparrelid E, Isaksson B, Lundell L, Nowak G, Stromberg C. Mortality-related risk factors and long-term survival after 4460 liver resections in Sweden-a population-based study. Langenbecks Arch Surg. 2017 Feb;402(1):105-113. doi: 10.1007/s00423-016-1512-2. Epub 2016 Oct 1.
Results Reference
background
PubMed Identifier
22943842
Citation
Cannon RM, Scoggins CR, Callender GG, McMasters KM, Martin RC 2nd. Laparoscopic versus open resection of hepatic colorectal metastases. Surgery. 2012 Oct;152(4):567-73; discussion 573-4. doi: 10.1016/j.surg.2012.07.013. Epub 2012 Sep 1.
Results Reference
background
PubMed Identifier
25902703
Citation
Beppu T, Wakabayashi G, Hasegawa K, Gotohda N, Mizuguchi T, Takahashi Y, Hirokawa F, Taniai N, Watanabe M, Katou M, Nagano H, Honda G, Baba H, Kokudo N, Konishi M, Hirata K, Yamamoto M, Uchiyama K, Uchida E, Kusachi S, Kubota K, Mori M, Takahashi K, Kikuchi K, Miyata H, Takahara T, Nakamura M, Kaneko H, Yamaue H, Miyazaki M, Takada T. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):711-20. doi: 10.1002/jhbp.261. Epub 2015 May 21.
Results Reference
background
PubMed Identifier
14631224
Citation
Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003 Dec;238(6):871-83; discussion 883-4. doi: 10.1097/01.sla.0000098112.04758.4e.
Results Reference
background
PubMed Identifier
26154803
Citation
Bonjer HJ, Deijen CL, Haglind E; COLOR II Study Group. A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer. N Engl J Med. 2015 Jul 9;373(2):194. doi: 10.1056/NEJMc1505367. No abstract available.
Results Reference
background
PubMed Identifier
23095612
Citation
Farges O, Goutte N, Bendersky N, Falissard B; ACHBT-French Hepatectomy Study Group. Incidence and risks of liver resection: an all-inclusive French nationwide study. Ann Surg. 2012 Nov;256(5):697-704; discussion 704-5. doi: 10.1097/SLA.0b013e31827241d5.
Results Reference
background
PubMed Identifier
24365035
Citation
Tranchart H, Dagher I. Laparoscopic liver resection: a review. J Visc Surg. 2014 Apr;151(2):107-15. doi: 10.1016/j.jviscsurg.2013.10.003. Epub 2013 Dec 22.
Results Reference
background
PubMed Identifier
19801926
Citation
Vigano L, Laurent A, Tayar C, Tomatis M, Ponti A, Cherqui D. The learning curve in laparoscopic liver resection: improved feasibility and reproducibility. Ann Surg. 2009 Nov;250(5):772-82. doi: 10.1097/SLA.0b013e3181bd93b2.
Results Reference
background
PubMed Identifier
19801934
Citation
Castaing D, Vibert E, Ricca L, Azoulay D, Adam R, Gayet B. Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centers. Ann Surg. 2009 Nov;250(5):849-55. doi: 10.1097/SLA.0b013e3181bcaf63.
Results Reference
background
PubMed Identifier
25791030
Citation
Hasegawa Y, Nitta H, Sasaki A, Takahara T, Itabashi H, Katagiri H, Otsuka K, Nishizuka S, Wakabayashi G. Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center. Surgery. 2015 Jun;157(6):1065-72. doi: 10.1016/j.surg.2015.01.017. Epub 2015 Mar 16.
Results Reference
background
PubMed Identifier
27486002
Citation
Karagkounis G, Akyuz M, Guerron AD, Yazici P, Aucejo FN, Quintini C, Miller CM, Vogt DP, Fung JJ, Berber E. Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients. Surgery. 2016 Oct;160(4):1097-1103. doi: 10.1016/j.surg.2016.04.043. Epub 2016 Jul 30.
Results Reference
background
PubMed Identifier
25282529
Citation
Schiffman SC, Kim KH, Tsung A, Marsh JW, Geller DA. Laparoscopic versus open liver resection for metastatic colorectal cancer: a metaanalysis of 610 patients. Surgery. 2015 Feb;157(2):211-22. doi: 10.1016/j.surg.2014.08.036. Epub 2014 Oct 1.
Results Reference
background
PubMed Identifier
26438480
Citation
Tohme S, Goswami J, Han K, Chidi AP, Geller DA, Reddy S, Gleisner A, Tsung A. Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery. J Gastrointest Surg. 2015 Dec;19(12):2199-206. doi: 10.1007/s11605-015-2962-5. Epub 2015 Oct 5.
Results Reference
background
PubMed Identifier
22358126
Citation
Topal H, Tiek J, Aerts R, Topal B. Outcome of laparoscopic major liver resection for colorectal metastases. Surg Endosc. 2012 Sep;26(9):2451-5. doi: 10.1007/s00464-012-2209-4. Epub 2012 Feb 23.
Results Reference
background
PubMed Identifier
22437957
Citation
Polignano FM, Quyn AJ, Sanjay P, Henderson NA, Tait IS. Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasis. Surg Endosc. 2012 Sep;26(9):2571-8. doi: 10.1007/s00464-012-2235-2. Epub 2012 Mar 22.
Results Reference
background
PubMed Identifier
20033324
Citation
Vanounou T, Steel JL, Nguyen KT, Tsung A, Marsh JW, Geller DA, Gamblin TC. Comparing the clinical and economic impact of laparoscopic versus open liver resection. Ann Surg Oncol. 2010 Apr;17(4):998-1009. doi: 10.1245/s10434-009-0839-0. Epub 2009 Dec 22.
Results Reference
background
PubMed Identifier
25130985
Citation
Wakabayashi G, Cherqui D, Geller DA, Han HS, Kaneko H, Buell JF. Laparoscopic hepatectomy is theoretically better than open hepatectomy: preparing for the 2nd International Consensus Conference on Laparoscopic Liver Resection. J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):723-31. doi: 10.1002/jhbp.139. Epub 2014 Aug 5.
Results Reference
background
PubMed Identifier
21107111
Citation
Kazaryan AM, Marangos IP, Rosok BI, Rosseland AR, Villanger O, Fosse E, Mathisen O, Edwin B. Laparoscopic resection of colorectal liver metastases: surgical and long-term oncologic outcome. Ann Surg. 2010 Dec;252(6):1005-12. doi: 10.1097/SLA.0b013e3181f66954.
Results Reference
background
PubMed Identifier
24753492
Citation
Makabe K, Nitta H, Takahara T, Hasegawa Y, Kanno S, Nishizuka S, Sasaki A, Wakabayashi G. Efficacy of occlusion of hepatic artery and risk of carbon dioxide gas embolism during laparoscopic hepatectomy in a pig model. J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):592-8. doi: 10.1002/jhbp.103. Epub 2014 Apr 21.
Results Reference
background
PubMed Identifier
20505504
Citation
Wu WC, Smith TS, Henderson WG, Eaton CB, Poses RM, Uttley G, Mor V, Sharma SC, Vezeridis M, Khuri SF, Friedmann PD. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg. 2010 Jul;252(1):11-7. doi: 10.1097/SLA.0b013e3181e3e43f.
Results Reference
background
PubMed Identifier
21207158
Citation
Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, DeMatteo RP, Strong VE. Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol. 2011 Jun;18(6):1599-605. doi: 10.1245/s10434-010-1517-y. Epub 2011 Jan 5.
Results Reference
background
PubMed Identifier
20466101
Citation
Pham TH, Perry KA, Dolan JP, Schipper P, Sukumar M, Sheppard BC, Hunter JG. Comparison of perioperative outcomes after combined thoracoscopic-laparoscopic esophagectomy and open Ivor-Lewis esophagectomy. Am J Surg. 2010 May;199(5):594-8. doi: 10.1016/j.amjsurg.2010.01.005.
Results Reference
background
PubMed Identifier
22330041
Citation
Nobili C, Marzano E, Oussoultzoglou E, Rosso E, Addeo P, Bachellier P, Jaeck D, Pessaux P. Multivariate analysis of risk factors for pulmonary complications after hepatic resection. Ann Surg. 2012 Mar;255(3):540-50. doi: 10.1097/SLA.0b013e3182485857.
Results Reference
background
PubMed Identifier
16618957
Citation
Lawrence VA, Cornell JE, Smetana GW; American College of Physicians. Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med. 2006 Apr 18;144(8):596-608. doi: 10.7326/0003-4819-144-8-200604180-00011.
Results Reference
background
PubMed Identifier
24854453
Citation
Soubrane O, Schwarz L, Cauchy F, Perotto LO, Brustia R, Bernard D, Scatton O. A Conceptual Technique for Laparoscopic Right Hepatectomy Based on Facts and Oncologic Principles: The Caudal Approach. Ann Surg. 2015 Jun;261(6):1226-31. doi: 10.1097/SLA.0000000000000737.
Results Reference
background
PubMed Identifier
26496309
Citation
Fretland AA, Sokolov A, Postriganova N, Kazaryan AM, Pischke SE, Nilsson PH, Rognes IN, Bjornbeth BA, Fagerland MW, Mollnes TE, Edwin B. Inflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases: Data From the Oslo-CoMet Trial. Medicine (Baltimore). 2015 Oct;94(42):e1786. doi: 10.1097/MD.0000000000001786. Erratum In: Medicine (Baltimore). 2016 Mar;95(10):e367e.
Results Reference
background
PubMed Identifier
22241289
Citation
Veenhof AA, Vlug MS, van der Pas MH, Sietses C, van der Peet DL, de Lange-de Klerk ES, Bonjer HJ, Bemelman WA, Cuesta MA. Surgical stress response and postoperative immune function after laparoscopy or open surgery with fast track or standard perioperative care: a randomized trial. Ann Surg. 2012 Feb;255(2):216-21. doi: 10.1097/SLA.0b013e31824336e2.
Results Reference
background
PubMed Identifier
25187072
Citation
Qiu J, Chen S, Pankaj P, Wu H. Laparoscopic hepatectomy is associated with considerably less morbidity and a long-term survival similar to that of the open procedure in patients with hepatic colorectal metastases. Surg Laparosc Endosc Percutan Tech. 2014 Dec;24(6):517-22. doi: 10.1097/SLE.0b013e31829cec2b.
Results Reference
background
PubMed Identifier
12131090
Citation
Gigot JF, Glineur D, Santiago Azagra J, Goergen M, Ceuterick M, Morino M, Etienne J, Marescaux J, Mutter D, van Krunckelsven L, Descottes B, Valleix D, Lachachi F, Bertrand C, Mansvelt B, Hubens G, Saey JP, Schockmel R; Hepatobiliary and Pancreatic Section of the Royal Belgian Society of Surgery and the Belgian Group for Endoscopic Surgery. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg. 2002 Jul;236(1):90-7. doi: 10.1097/00000658-200207000-00014.
Results Reference
background
PubMed Identifier
27613735
Citation
Okunrintemi V, Gani F, Pawlik TM. National Trends in Postoperative Outcomes and Cost Comparing Minimally Invasive Versus Open Liver and Pancreatic Surgery. J Gastrointest Surg. 2016 Nov;20(11):1836-1843. doi: 10.1007/s11605-016-3267-z. Epub 2016 Sep 9.
Results Reference
background
PubMed Identifier
24555996
Citation
Montalti R, Berardi G, Laurent S, Sebastiani S, Ferdinande L, Libbrecht LJ, Smeets P, Brescia A, Rogiers X, de Hemptinne B, Geboes K, Troisi RI. Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case-control matched-pairs analysis. Eur J Surg Oncol. 2014 May;40(5):536-544. doi: 10.1016/j.ejso.2014.01.005. Epub 2014 Feb 2.
Results Reference
background
PubMed Identifier
26454765
Citation
Nachmany I, Pencovich N, Zohar N, Ben-Yehuda A, Binyamin C, Goykhman Y, Lubezky N, Nakache R, Klausner JM. Laparoscopic versus open liver resection for metastatic colorectal cancer. Eur J Surg Oncol. 2015 Dec;41(12):1615-20. doi: 10.1016/j.ejso.2015.09.014. Epub 2015 Sep 30.
Results Reference
background
PubMed Identifier
26944725
Citation
Ratti F, Catena M, Di Palo S, Staudacher C, Aldrighetti L. Impact of totally laparoscopic combined management of colorectal cancer with synchronous hepatic metastases on severity of complications: a propensity-score-based analysis. Surg Endosc. 2016 Nov;30(11):4934-4945. doi: 10.1007/s00464-016-4835-8. Epub 2016 Mar 4.
Results Reference
background
PubMed Identifier
26583668
Citation
Allard MA, Cunha AS, Gayet B, Adam R, Goere D, Bachellier P, Azoulay D, Ayav A, Navarro F, Pessaux P; Colorectal Liver Metastases-French Study Group. Early and Long-term Oncological Outcomes After Laparoscopic Resection for Colorectal Liver Metastases: A Propensity Score-based Analysis. Ann Surg. 2015 Nov;262(5):794-802. doi: 10.1097/SLA.0000000000001475.
Results Reference
background
PubMed Identifier
27484847
Citation
Cipriani F, Rawashdeh M, Stanton L, Armstrong T, Takhar A, Pearce NW, Primrose J, Abu Hilal M. Propensity score-based analysis of outcomes of laparoscopic versus open liver resection for colorectal metastases. Br J Surg. 2016 Oct;103(11):1504-12. doi: 10.1002/bjs.10211. Epub 2016 Aug 3.
Results Reference
background
PubMed Identifier
11697390
Citation
Van Ness P. The concept of risk in biomedical research involving human subjects. Bioethics. 2001 Aug;15(4):364-70. doi: 10.1111/1467-8519.00244.
Results Reference
background
PubMed Identifier
26275554
Citation
Tranchart H, Fuks D, Vigano L, Ferretti S, Paye F, Wakabayashi G, Ferrero A, Gayet B, Dagher I. Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: a propensity score matching analysis. Surg Endosc. 2016 May;30(5):1853-62. doi: 10.1007/s00464-015-4467-4. Epub 2015 Aug 15.
Results Reference
background
PubMed Identifier
27500141
Citation
Untereiner X, Cagniet A, Memeo R, Tzedakis S, Piardi T, Severac F, Mutter D, Kianmanesh R, Marescaux J, Sommacale D, Pessaux P. Laparoscopic hepatectomy versus open hepatectomy for colorectal cancer liver metastases: comparative study with propensity score matching. Hepatobiliary Surg Nutr. 2016 Aug;5(4):290-9. doi: 10.21037/hbsn.2015.12.06.
Results Reference
background
PubMed Identifier
28151797
Citation
Martinez-Cecilia D, Cipriani F, Shelat V, Ratti F, Tranchart H, Barkhatov L, Tomassini F, Montalti R, Halls M, Troisi RI, Dagher I, Aldrighetti L, Edwin B, Abu Hilal M. Laparoscopic Versus Open Liver Resection for Colorectal Metastases in Elderly and Octogenarian Patients: A Multicenter Propensity Score Based Analysis of Short- and Long-term Outcomes. Ann Surg. 2017 Jun;265(6):1192-1200. doi: 10.1097/SLA.0000000000002147.
Results Reference
background
PubMed Identifier
28138958
Citation
Wong-Lun-Hing EM, van Dam RM, van Breukelen GJ, Tanis PJ, Ratti F, van Hillegersberg R, Slooter GD, de Wilt JH, Liem MS, de Boer MT, Klaase JM, Neumann UP, Aldrighetti LA, Dejong CH; ORANGE II Collaborative Group. Randomized clinical trial of open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery after surgery programme (ORANGE II study). Br J Surg. 2017 Apr;104(5):525-535. doi: 10.1002/bjs.10438. Epub 2017 Jan 31.
Results Reference
background
PubMed Identifier
28364151
Citation
Elshamy M, Takahashi H, Akyuz M, Yazici P, Yigitbas H, Hammad AY, Aucejo FN, Quintini C, Fung J, Berber E. Evolution of a laparoscopic liver resection program: an analysis of 203 cases. Surg Endosc. 2017 Oct;31(10):4150-4155. doi: 10.1007/s00464-017-5468-2. Epub 2017 Mar 31.
Results Reference
background
PubMed Identifier
15273542
Citation
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.
Results Reference
background
PubMed Identifier
25379846
Citation
Slankamenac K, Nederlof N, Pessaux P, de Jonge J, Wijnhoven BP, Breitenstein S, Oberkofler CE, Graf R, Puhan MA, Clavien PA. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014 Nov;260(5):757-62; discussion 762-3. doi: 10.1097/SLA.0000000000000948.
Results Reference
background
PubMed Identifier
16327492
Citation
Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005 Dec;242(6):824-8, discussion 828-9. doi: 10.1097/01.sla.0000189131.90876.9e.
Results Reference
background
PubMed Identifier
19153324
Citation
Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y, Sugawara Y, Makuuchi M. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg. 2009 Jan;144(1):46-51. doi: 10.1001/archsurg.2008.511.
Results Reference
background
PubMed Identifier
21316725
Citation
Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, Fan ST, Yokoyama Y, Crawford M, Makuuchi M, Christophi C, Banting S, Brooke-Smith M, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Nimura Y, Figueras J, DeMatteo RP, Buchler MW, Weitz J. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011 May;149(5):680-8. doi: 10.1016/j.surg.2010.12.002. Epub 2011 Feb 12.
Results Reference
background
PubMed Identifier
1332552
Citation
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control. 1992 Oct;20(5):271-4. doi: 10.1016/s0196-6553(05)80201-9. No abstract available.
Results Reference
background
PubMed Identifier
21762295
Citation
Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, Hugh TJ, Fan ST, Nimura Y, Figueras J, Vauthey JN, Rees M, Adam R, Dematteo RP, Greig P, Usatoff V, Banting S, Nagino M, Capussotti L, Yokoyama Y, Brooke-Smith M, Crawford M, Christophi C, Makuuchi M, Buchler MW, Weitz J. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford). 2011 Aug;13(8):528-35. doi: 10.1111/j.1477-2574.2011.00319.x. Epub 2011 Jun 7.
Results Reference
background
PubMed Identifier
25846843
Citation
Cauchy F, Fuks D, Nomi T, Schwarz L, Barbier L, Dokmak S, Scatton O, Belghiti J, Soubrane O, Gayet B. Risk factors and consequences of conversion in laparoscopic major liver resection. Br J Surg. 2015 Jun;102(7):785-95. doi: 10.1002/bjs.9806. Epub 2015 Apr 2.
Results Reference
background
PubMed Identifier
19224519
Citation
Blazeby JM, Fayers P, Conroy T, Sezer O, Ramage J, Rees M; European Organization for Research Treatment of Cancer (EORTC) Quality of Life Group. Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases. Br J Surg. 2009 Mar;96(3):291-8. doi: 10.1002/bjs.6471.
Results Reference
background
PubMed Identifier
17549635
Citation
Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007 Sep;8(3):206-13. doi: 10.1007/s11121-007-0070-9. Epub 2007 Jun 5.
Results Reference
background

Learn more about this trial

Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases

We'll reach out to this number within 24 hrs